MUMBAI, India, November 30, 2012 /PRNewswire/ --
SIRO Clinpharm, a leading full service Clinical Research Organization, announced the deployment of one of the biggest IT advancement projects in the region - Oracle Health Sciences InForm - an integrated life sciences solution with all the tools required to efficiently conduct and manage EDC-based clinical trials.
The application of Oracle Health Sciences InForm enables SIRO to automate and streamline solutions for the global biopharma and medical devices companies in their clinical development process across therapeutic areas and phases. With a breadth of services encompassing clinical operations, clinical data management, medical writing, biostatistics and statistical programming, pharmacovigilance and clinical trial supplies management, this comes as a huge step toward adopting global trial processes, as EDC systems are widely used across Western Europe and the United States.
"Our IT capabilities in the region are second to none. By deploying Oracle Health Sciences InForm, we have upgraded our technology platforms to global standards. Combined with our expertise in clinical development, we can now offer our clients a very effective and seamless user experience," said Khushru Patel, Global Head, Information Technology. "The software's flexibility, scalability and real-time access to trial data streamline and accelerate large and complex international trials.""We help our clients take advantage of technology developments to tackle dynamic regulatory environments, escalating disease complications and fierce competition to get products to the market," said Gopakumar Menon, CEO. About SIRO Clinpharm: SIRO Clinpharm, winner of Frost & Sullivan ' Clinical Research Organization of the year 2012 ' India Healthcare Award, is a drug development solutions provider to the global healthcare industry. Our subject expertise gives us an edge in clinical data management, medical writing, biostatistics, clinical trial management and clinical trial supplies. Our therapeutic experience includes but is not limited to oncology, diabetes, cardiology, infectious diseases & respiratory disorders. We offer flexible business models across service verticals based on client needs.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts